APIXABAN

Clinical Indication

Treatment and secondary prevention of DVT and PE

Comments

In line with NICE TA 341

Date of classification

September 2015

Yellow

Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.